Your trusted source for investing success

Tag: medical products

CTD Holdings Presents Compassionate Use Data on Trappsol(R) Cyclo(TM) to Treat Niemann-Pick Disease Type C and Provides Update on Progress of U.S. and EU Clinical Trials at 13th Annual WORLDSymposium

CTD Holdings, Inc. (OTCQB: CTDH), a clinical-stage biotechnology company that develops cyclodextrin-based products for the treatment of disease, presented updated compassionate use data regarding the Company’s proprietary formulation of hydroxypropyl beta cyclodextrin, Trappsol® Cyclo™, for the treatment of Niemann-Pick Disease Type C (NPC). The data were presented in a poster

Utah Medical Products Announces Quarterly Dividend

Utah Medical Products, Inc. (NASDAQ: UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-six and one-half cents ($.265) per share of common stock payable on April 4, 2017 to shareholders of record at the close of business on March 17, 2017. This is a 2% increase

ResMed and BMC/3B Medical Settle Global Litigation

ResMed (NYSE:RMD), BMC (Beijing, China) and 3B Medical (Winter Haven, Florida) today announced they have agreed on a global settlement of all litigation between the parties. BMC and 3B will be permitted to sell their existing products in exchange for royalty payments to ResMed, and ResMed will make a one-time

Enter Your Log In Credentials
×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network